IRVINE, Calif.–(BUSINESS WIRE)– Endologix Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today the completion of enrollment in the Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft (ELEVATE) IDE clinical study. The objective of the 75-patient study is to evaluate the safety and effectiveness of […]
Other News
Teleflex Announces U.S. Launch of Two Next-Generation Versions of Its 0.035” Snares for Peripheral Procedures
Expro Elite™ Snare features a helical loop and Sympro Elite™ Snare features a simple 90-degree loop – both devices are available in five loop diameters for clinical versatility in retrieving or repositioning intravascular devices – preassembled, one-piece design allows rapid deployment through any 0.035” compatible lumen. WAYNE, Pa.–(BUSINESS WIRE)– Teleflex Incorporated (NYSE: […]
JenaValve Technology Appoints Laura A. Brenton as Vice President of Clinical and International Market Development
Feb. 2, 2018 14:00 UTC IRVINE, Calif.–(BUSINESS WIRE)– JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive Laura A. Brenton as Vice President of Clinical and International Market […]
ClearFlow Release: Studies Recognizing the Importance of Limiting Retained Blood to Prevent Postoperative Atrial Fibrillation Featured on January Cover of Annals of Thoracic Surgery
Feb. 1, 2018 19:16 UTC –ClearFlow spokespeople cite review article as latest piece of mounting evidence pertaining to urgent need for managing retained blood after surgery– ANAHEIM, Calif.–(BUSINESS WIRE)– ClearFlow, a medical device company based in Anaheim, CA., has announced that the cover of the January 2018 issue of The Annals of […]
TVA Medical Release: Meta-Analysis Demonstrates Positive Clinical Experience Using everlinQ™ endoAVF System for Hemodialysis Acces
Results from 236 patients across 28 sites in seven countries presented at LINC 2018 support growing body of evidence for pioneering clinical approach [01-February-2018] LEIPZIG, Germany, Feb. 1, 2018 /PRNewswire/ — An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for hemodialysis access was […]
Cardiovascular Systems, Inc. Announces Commercial Launch in Japan
First Patient Treated by Dr. Shigeru Saito at Shonan Kamakura General Hospital ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that it has commercially treated the first patient in […]
Procyrion Banks $16M for Breakthrough Aortix Heart Pump
Procyrion Raises $16 Million Series C for Clinical Trials of Its Breakthrough Aortix Heart Pump Houston, TX (January 30, 2018) – Procyrion, Inc., a clinical-stage medical device company, today announced the completion of a $16 million Series C funding round led by an affiliate of Fannin Partners. Returning investors include […]
Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer™ Procedure for Treatment of Refractory Angina
Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure NASDAQ, TSX: NVCN VANCOUVER, Feb. 1, 2018 /PRNewswire/ – Neovasc, Inc. (NVCN) (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve technologies, today announced that the “Institut für das Entgeltsystem im […]
Successful Clinical Application of China’s First Transcatheter Mitral Valve Repair Device, MitralStitch
HANGZHOU, China, Feb. 1, 2018 /PRNewswire/ — On January 19, 2018, the global first clinical case of MitralStitch™ mitral valve repair system was completed at Yunnan Fuwai Hospital, China. This operation was jointly performed by the team of Professor Pan Xiangbin and Professor Meng Xu from Beijing Anzhen Hospital under the guidance of Academician Hu Shengshou […]
LivaNova Announces CE Mark for PureFlex Arterial Cannulae Line for Conventional Cardiac Surgery
Company celebrates new design that delivers improved flexibility, clarity and control LONDON–(BUSINESS WIRE)– LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it has achieved CE Mark for its new PureFlexTM line of adult arterial cannulae. Engineered to improve the critical link between the patient and extracorporeal circulation, […]
